Brief: Dr. Lal Pathlabs - Unit To Buy Bindish Diagnostic Lab On Going Concern Basis
Nov 6 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* DR. LAL PATHLABS LTD - UNIT TO BUY BINDISH DIAGNOSTIC
LABORATORY ON A GOING CONCERN BASIS
* DR. LAL PATHLABS LTD - BINDISH DEAL CONSIDERATION FOR NOT
EXCEEDING 40 MILLION RUPEES
* DR. LAL PATHLABS - UNIT TO BUY 70% STAKE IN CHANRE
DIAGNOSTIC
SERVICES FOR CONSIDERATION NOT EXCEEDING 175 MILLION RUPEES
Source text for Eikon: ID:nBSE8t8CXP
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise